Cecília Horta Ramalho-Pinto

Cecília Horta Ramalho-Pinto

Auto-generated profile, based on publicly available information

Cecília Horta Ramalho-Pinto

Departamento de Bioquimica e Imunologia-Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2024 in Journal of Leukocyte Biology
Verified
Journal Article
Closed access
PDF file
CRCecília Horta Ramalho-Pinto
Cecília Horta Ramalho-Pinto
LVLucas Haniel de Araújo Ventura
Lucas Haniel de Araújo Ventura
GCGiovanna Caliman Camatta
Giovanna Caliman Camatta
GSGabriela Silveira-Nunes
Gabriela Silveira-Nunes
MGMatheus de Souza Gomes
Matheus de Souza Gomes
AFAna Maria Caetano Faria
Ana Maria Caetano Faria
Although the SARS-CoV-2 infection has established risk groups, identifying biomarkers for disease outcomes is still crucial to stratify patient risk and enhance clinical management. Optimal efficacy of COVID-19 antiviral medications relies on early administration within the initial 5 d of symptoms, assisting high-risk patients in avoiding hospitalization and improving survival chances. The complete blood count (CBC) can be an efficient and affordable option to find biomarkers that predict the COVID-19 prognosis due to infection-induced alterations in various blood parameters. This study aimed to associate hematological parameters with different COVID-19 clinical forms and utilizes them as disease outcome predictors. We performed a CBC in blood samples from 297 individuals with COVID-19 from Belo Horizonte, Brazil. Statistical analysis, as well as ROC Curves and machine learning Decision Tree algorithms were used to identify correlations, and their accuracy, between blood parameters and disease severity. In the initial 4 d of infection, traditional hematological COVID-19 alterations, such as lymphopenia, were not yet apparent. However, the monocyte percentage and granulocyte-to-lymphocyte ratio (GLR) proved to be reliable predictors for hospitalization, even in cases where patients exhibited mild symptoms that later progressed to hospitalization. Thus, our findings demonstrate that COVID-19 patients with monocyte percentages lower than 7.7% and a GLR higher than 8.75 are assigned to the hospitalized group with a precision of 86%. This suggests that these variables can serve as important biomarkers in predicting disease outcomes and could be used to differentiate patients at hospital admission for managing therapeutic interventions, including early antiviral administration. Moreover, they are simple parameters that can be useful in minimally equipped health care units.

18 November 2024 in medRxiv
Verified
Preprint
Open access
PDF file
LVLucas Haniel Araujo Ventura
Lucas Haniel Araujo Ventura
LTLícia Torres
Lícia Torres
GCGiovanna Caliman Camatta
Giovanna Caliman Camatta
JZJofer Zamame
Jofer Zamame
MCMonique Macedo Coelho
Monique Macedo Coelho
AFAna Maria Caetano Faria
Ana Maria Caetano Faria
In this study we tested the hypothesis that the immunosenescence profile could account for the disproportional susceptibility of the elderly to severe forms of COVID-19. The immunological profiles of volunteers residing in endemic and non-endemic areas for chronic infectious diseases were analyzed at early stage of SARS-CoV-2 infection. A unique signature of inflammatory plasma mediators was identified in COVID-19 volunteers when compared to individuals with other flu-like syndromes. COVID-19 severity correlated with high levels of inflammatory mediators; among them, CXCL9, a serum marker of aging. Patients who progressed to hospitalization displayed high frequencies of CD8 + and CD4 + T cells expressing exhaustion and senescence markers and showed reduced and more mature B cell repertoires, which are typical of senescence. They also had an acceleration of epigenetic age measured by DNA methylation. Therefore, severe COVID-19 correlated with phenotypic, functional, and epigenetic features of accelerated immunosenescence at onset of infection.